Sponsor Pipeline

Second Hospital of Shanxi Medical University Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
9
Active Trials
2
Recruiting
2
Disease Areas
Active Trials by Phase
Phase 2
1
Early Phase 1
1
Not specified
7
Active Trials
NCT IDTitleConditionStatus
Phase 2
NCT06536868 Tislelizumab Combined With Chemotherapy and Thoracic Radiotherapy in ES-SCLC Extensive-stage Small-cell Lung Cancer Recruiting
Early Phase 1
NCT07012902 Relationship Between Remimazolam and Etomidate in Induction of General Anesthesia Induction Anesthesia Not Yet Recruiting
Not specified
NCT06570317 Nintedanib for the Prevention of Radiation Pneumonia in Unresectable NSCLC NSCLC Recruiting
NCT06808841 Sufentanil in Patients With Lower Extremity Fracture Surgery Myocardial Damage Function… Myocardial Injury Not Yet Recruiting
NCT06947551 The Mechanism of Endogenous Nociceptin/Orphanin FQ(N/OFQ) and β1-adrenoceptor… Acute Myocardial Ischemia Not Yet Recruiting
NCT06990763 Network Pharmacology Was Applied to Explore the Mechanism of Remimazolam Applied in… Gynecological Disease Not Yet Recruiting
NCT06991985 Analysis of Factors Associated With The Occurrence of Amniotic Fluid Entry in Patients… Amniotic Fluid Embolism Not Yet Recruiting
NCT07595887 Ultrasound Assessment of Sciatic Nerve and Inferior Gluteal Artery in Diabetic Peripheral… Diabetic Peripheral Neuropathy (DPN) Not Yet Recruiting
NCT07654075 Transcutaneous Electrical Acupoint Stimulation for Perioperative Sleep Disturbances in… Postoperative Sleep Disturbance Not Yet Recruiting
Disease Areas
Get alerts when Second Hospital of Shanxi Medical University's trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free